跳至主要内容
临床试验/NCT01539239
NCT01539239已完成不适用

The Safety and Effectiveness of the Hydrus Aqueous Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery, A Prospective, Multicenter, Randomized, Controlled Clinical Trial

Ivantis, Inc.38 个研究点 分布在 9 个国家目标入组 1,143 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Ivantis, Inc.
入组人数
1,143
试验地点
38
主要终点
Reduction in Mean Diurnal IOP From Baseline at 24 Months Following Medication Washout.

研究概览

简要总结

This clinical trial is a prospective, randomized, controlled, multicenter, study. After informed consent is obtained, patients will be evaluated for eligibility based on glaucoma severity, eye health, and visual acuity. Following successful screening, use of all topical glaucoma medications will be stopped for a period of "washout" to establish a qualifying medication-free intraocular pressure (IOP) value. Clinical follow up will be scheduled over the course of the 24 month study, and examinations will be repeated to monitor eye health. At the 1 and 2 year follow up, those patients on ocular hypotensive medications will be instructed to washout, and then have the diurnal (IOP taken in the morning, mid-day, and afternoon in the same day) IOP evaluation. Annual follow up will occur up to 5 years. The primary effectiveness endpoint is a decrease in diurnal IOP from baseline compared to the 24 months diurnal IOP following medication washout.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • An operable age-related cataract
  • A diagnosis of POAG treated with 1 to 4 hypotensive medications
  • Medicated IOP ≤ 31 mmHg
  • Diurnal IOP ≥ 22 mmHg and ≤ 34 mmHg

排除标准

  • Congenital or developmental glaucoma
  • Previous argon laser trabeculoplasty
  • Ab-interno or ab-externo device implanted in or through Schlemm's Canal
  • Use of oral hypotensive medication for glaucoma for treatment of fellow eye

结局指标

主要结局

Reduction in Mean Diurnal IOP From Baseline at 24 Months Following Medication Washout.

时间窗: Baseline and 24 months

Percentage of eyes in which diurnal IOP was reduced by greater than or equal to 20% at 24 months postoperative compared to baseline after washout of topical glaucoma medications.

次要结局

  • Mean Diurnal Washed Out IOP Change From Baseline at 24 Months Compared Between Treatment and Control Groups.(Baseline and 24 months)

研究者

发起方
Ivantis, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (38)

Loading locations...

相似试验